Insulet earnings were $246.2M for the trailing 12 months ending Sep 30, 2025, with -41.9% growth year over year. The latest PODD earnings report on Sep 30, 2025 announced Q3 2025 earnings of $87.6M, up 289.3% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, PODD reported annual earnings of $418.3M, with 102.8% growth.
PODD past earnings growth
How has PODD's earnings growth performed historically?
On PODD's earnings call on Invalid Date, Insulet (NASDAQ: PODD) reported Q3 2025 earnings per share (EPS) of $1.24, up 11.71% year over year. Total PODD earnings for the quarter were $87.60 million. In the same quarter last year, Insulet's earnings per share (EPS) was $1.11.
As of the last Insulet earnings report, Insulet is currently profitable. Insulet's net profit (also called net income) for the twelve months ending Sep 30, 2025 was $246.20 million, a 41.51% decrease year over year.
What was PODD's earnings growth in the past year?
As of Insulet's earnings date in Invalid Date, Insulet's earnings has grown -41.86% year over year. This is 92.12 percentage points lower than the US Medical Devices industry earnings growth rate of 50.26%. PODD earnings in the past year totalled $246.20 million.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.